Tag: ALK

ARUP Laboratories and Applied Spectral Imaging Bring Medical Innovation to Pathology

| November 13, 2017 | 0 Comments

Collaboratively Develop System Designed to Transform How Pathologists Perform FISH CARLSBAD, California, Nov. 13, 2017 — ARUP Laboratories, a national pathology reference laboratory, and Applied Spectral Imaging (ASI), a global leader in computer-assisted biomedical imaging, announced today they have completed a multi-year collaboration, leading to the launch of ASI’s PathFusion™, a cutting-edge solution that combines Whole […]

Continue Reading

Applied Spectral Imaging Announces Its GenASIs Applications Comply with CE-IVD Requirements with the IQFISH Lung Cancer Panel on Dako Omnis of Agilent Technologies Inc

| January 11, 2017 | 0 Comments

Carlsbad, CA – January 11, 2017 – Applied Spectral Imaging (ASI) announced today that its GenASIsTM  applications comply with CE-IVD requirements under the European Directive on In Vitro Diagnostic Medical Devices, for automated analysis with the IQFISH lung cancer panel on Dako Omnis (comprising of ALK, ROS1, RET and MET IQFISH probes) of Agilent Technologies […]

Continue Reading

Three Events – One Product Family! Join ASI in March!

| March 17, 2015 | 0 Comments

Three Events – One Product Family! Join Applied Spectral Imaging at the following events in March to learn about ASI’s GenASIs Platform. Accurate. Standardized. Immediate USCAP 2015 – United States & Canadian Academy of Pathology Annual Meeting March 23-25 | Hynes Convention Center, Boston, MA, USA | Booth # 519 ACMG 2015 – Annual Clinical […]

Continue Reading

ASI’s Webinar – July 29, 2014 – Register Now – Digital Pathology On Your Microscope

| July 25, 2014 | 0 Comments

ASI’s Webinar – July 29, 2014 – Register Now – Digital Pathology On Your Microscope A complete solution for FISH, CISH and IHC Applied Spectral Imaging Inc. develops computer aided image analysis & diagnostic tools for clinical and research applications. The GenASIs platform integrates within the existing workflow of the microscope, pathologist and LIS framework, […]

Continue Reading

Molecular medicine – can we afford it?

Since the time I was a medical student, we were taught that for many of us, particularly those interested in pathology and laboratory medicine, that our jobs would be replaced by small computer chips and software applications that could predict clinical behavior of tumors and guide more personalized therapies with minimal cytotoxicity. For nearly 100 years, […]

Continue Reading